Application of activating properties of NKG2D may be performed by enhancing its action, leading to increased cytotoxicity of NK cells or, on the other hand, the inhibition of NK activation can be used to facilitate the treatment of autoimmune diseases or enhance the GvT (GvL) effect. This evidence concerns the gene KLRK1 and autoimmune disease.